GPs advised to review all patients on aspirin for primary prevention.

The largest analysis to date into the effects of aspirin found no reduction in cardiovascular death yet a 30% increase in life-threatening or debilitating internal bleeding events.

Data from nine trials and 100,000 participants found a modest reduction in non-fatal heart attacks, but that 120 people would have to be treated to prevent one event – compared with the one in 73 who suffered potentially significant bleeding.

Graham

http://www.pulsetoday.co.uk/newsarticle-content/-/article_display_list/13287359/gps-advised-to-review-all-patients-on-aspirin-for-primary-prevention